Richard Schottenfeld, MD
Senior Research ScientistCards
About
Research
Overview
- Combining Behavioral Treatments with Opioid Agonist Maintenance Treatment: In studies in Malaysia, Iran and China, we are evaluating the efficacy and cost-effectiveness of behavioral drug and HIV risk reduction counseling when provided along with methadone or buprenorphine maintenance treatment.
- Pain and Opioid Dependence: We are evaluating buprenorphine treatment and integrated pain and opioid dependence behavioral therapy for patients with co-occurring chronic pain and opioid dependence.
Medical Research Interests
Academic Achievements & Community Involvement
Clinical Care
Overview
Richard Schottenfeld, MD, is a psychiatrist specializing in addiction medicine. He focuses on treating individuals with opioid dependence and other substance-related disorders.
Dr. Schottenfeld offers integrated treatments that combine behavioral therapies with opioid agonist maintenance, helping patients manage co-occurring conditions such as chronic pain.
As a senior research scientist at Yale School of Medicine, Dr. Schottenfeld is involved in research to improve opioid dependence treatment. His studies have explored ways to integrate addiction treatment into general in-office medical services and have assessed behavioral interventions to reduce drug and HIV risk. His international projects include evaluating treatment approaches in Malaysia, Iran, and China. His work aims to make addiction treatments more effective and accessible.
Dr. Schottenfeld received his medical training from Yale School of Medicine.
Clinical Specialties
Yale Medicine News
Get In Touch
Contacts
Psychiatry
300 George St
New Haven, CT 06511-
United States